drugset / Trial / NCT07705022
Assessing Covert Consciousness During Dexmedetomidine and Ketamine Sedation: An fMRI Study
Phase 2
Not yet recruiting
60 enrolled
University of Michigan
National Institute of General Medical Sciences (NIGMS) · collab
RandomizedParallel-groupSingle-blindBasic science
Summary
This research is studying whether mental functions take place during different levels of anesthesia, using a commonly used drug (either dexmedetomidine \[with propofol in some participants\] or ketamine), which shows areas in the brain involved in thinking at different depths of anesthesia. As a result of this study, the researchers expect to gain a deeper understanding of mental function during different levels of anesthesia.
Timeline
- Start
- 2026-07
- Primary completion
- 2028-01
- Completion
- 2028-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.2 ug/kg | Intravenous |
| Subject | Dexmedetomidine | Other / unclassified | 1 ug/kg | Intravenous |
| Subject | Ketamine | Small molecule | 0.5 mg/kg | Intravenous |
| Subject | Ketamine | Small molecule | 1.5 mg/kg | Intravenous |
| Background | Propofol | Small molecule | 0.5 ug/ml | — |
| Background | Propofol | Small molecule | 1.5 ug/ml | — |
Indications
No indication recorded.